IFN-alpha therapy is effective in suppressing the clinical experimental myasthenia gravis.

Source:http://linkedlifedata.com/resource/pubmed/id/8955221

J. Immunol. 1996 Dec 15 157 12 5675-82

Download in:

View as

General Info

PMID
8955221